Takeda Pharmaceutical as of Sept. 30, 2025
Portfolio Holdings for Takeda Pharmaceutical
Takeda Pharmaceutical holds 8 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ovid Therapeutics (OVID) | 59.8 | $9.8M | 7.5M | 1.30 | |
| Equillium (EQ) | 15.9 | $2.6M | 1.8M | 1.43 | |
| Xilio Therapeutics (XLO) | 7.6 | $1.2M | 1.5M | 0.84 | |
| Shattuck Labs (STTK) | 7.5 | $1.2M | 516k | 2.39 | |
| Lyell Immunopharma | 5.4 | $891k | 55k | 16.24 | |
| American Well Corp-class A (AMWL) | 2.9 | $478k | 78k | 6.15 | |
| Rani Therapeutics Hldgs (RANI) | 0.6 | $102k | 203k | 0.50 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $22k | 17k | 1.30 |
